Smoking Cessation at Lung Examination (Part 2): Lessons Learned and Next Steps from the NCI SCALE Collaboration Webinar-Smoking Cessation at Lung Examination (Part 2): Lessons Learned and Next Steps from the NCI SCALE Collaboration Webinar

Video Transcription

Video Summary

In a recent webinar, experts shared findings from studies on integrating smoking cessation into lung cancer screening programs. Key trial outcomes and lessons were discussed by Drs. Benjamin Toll, Andrea Foley, Randy Williams, Kate Taylor, Stephen Fu, Jennifer Minix, and Jamie Ostroff.<br /><br />Dr. Foley presented the OASIS trial, emphasizing the importance of integrating tobacco cessation at community oncology sites using evidence-based strategies, such as educational webinars and local resource planning. This pragmatic trial highlighted both opportunities and challenges in real-world implementation, especially concerning the heterogeneity of clinics.<br /><br />Drs. Williams and Taylor discussed their study at Georgetown University, which compared intensive counseling plus nicotine replacement therapy to a minimal intervention. They found initial advantages with intensive intervention diminishing over time, prompting ongoing trials to refine approaches, including assessing cost-effectiveness from a health system perspective.<br /><br />Dr. Fu presented the Pluto trial, which tested tailored, longitudinal behavioral coaching with dual nicotine replacement. The trial found significant long-term quit rates, underscoring the benefits of continuous engagement with quitters. The VA's broader implementation efforts aim to scale these interventions nationally.<br /><br />Dr. Minix shared results from MD Anderson’s trial, advocating for integrated care models due to higher cessation rates. The study also acknowledged the feasibility of Quitline-based approaches in settings with limited resources.<br /><br />Dr. Ostroff used a factorial trial to identify cost-effective, efficient tobacco treatment interventions, emphasizing the need for strategic decision-making to optimize resources.<br /><br />Contributors underscored the necessity for dedicated funding and systematically incorporating tobacco treatment into lung cancer screening to improve outcomes. They emphasized early intervention and personalization for sustainable smoking cessation.

Asset Subtitle

Video

Keywords

smoking cessation

lung cancer screening

OASIS trial

behavioral coaching

Quitline

integrated care models

cost-effectiveness

personalization

tobacco treatment

evidence-based strategies